Market By System, Applications, And Geography | Forecast 2019-2027
The detailed analysis of the global neurostimulation device market shows that in terms of revenue, the market is estimated to grow at a CAGR of 10.23% during the forecasting years 2019-2027. The market is expected to generate a revenue of $11899.1 million by the year 2027. The implantable devices used for neuromodulation are referred to as neurostimulation devices or neurostimulators.
Report scope can be customized per your requirements. Request For Customization
Neurostimulation is a potential alternative for individuals unresponsive to drug therapy or surgeries. Neurostimulation devices help in the therapeutic activation of the nervous system. These implantable devices send electrical stimuli to the brain, spinal cord, and other organs, playing an integral function in the nervous system. The neurostimulator sends a target-specific stimulus that inhibits the passage of pain signals to the brain. Healthcare experts use these devices to treat various neurological disorders such as epilepsy, pain, depression, Parkinson’s disease, obsessive-compulsive disorder, dystonia, and tremor, which will likely boost the neurostimulation device market.
The study aims to get an overview of the neurostimulation device market in terms of various factors. Within this report, the market definition and the key insights regarding the neurostimulation device market have been discussed. Also, the value chain outlook, market trends, market share outlook, Pestle outlook, and market attractiveness index have been studied in detail.
Market drivers like the rising incidence of neuro diseases, increasing geriatric population, growing demand for MRI scans, and favorable reimbursement policies are driving the neurostimulation device market growth. However, the market is facing market restraints like the high cost of neuromodulation treatment and the presence of alternative therapy, which are obstructing the market growth.
Key opportunities like the high market potential for SCS devices in neurostimulation, technological development, and growing incidence of chronic discomfort can be leveraged by the market to reach the projected growth. However, challenges such as stringent regulatory approvals and side-effects of associated neurostimulation devices are being faced by this market.
To get detailed insights on segments, Download Sample Report
Geographies covered in the neurostimulation device market by region are:
• North America: The United States and Canada
• Asia-Pacific: China, Japan, India, South Korea, Australia & New Zealand, ASEAN countries and Rest of Asia-Pacific
• Europe: The United Kingdom, Germany, Italy, Russia, Spain, France and Rest of Europe
• Latin America: Brazil, Mexico and Rest of Latin America
• Middle East & Africa: Turkey, the United Arab Emirates, South Africa, Saudi Arabia, and the Rest of Middle East & Africa
The neurostimulation device market has been segmented as follows:
• By System
O Spinal cord stimulators
O Gastric electric stimulator
O Sacral nerve stimulators
O Deep brain stimulators
O Vagus nerve stimulators
O Other systems
• By Application
O Gastroparesis
O Pain management
O Depression
O Parkinson’s disease
O Epilepsy
O Essential tremor
O Urinary and fecal incontinence
O Dystonia
O Other applications
The key players engaged in the neurostimulation device market are Aleva Neurotherapeutics SA, Boston Scientific Corporation, Cogentix Medical, Inc., Cyberonics, Inc., DePuy Synthes Companies, Dr. Langer Medical GmbH, Ectron Limited, Ekso Bionics Holding Inc., Helius Medical Technologies, Hocoma AG, Medtronic plc, Neuronetics, Inc., Nevro Corp., St. Jude Medical, Inc. (acquired by Abbott Laboratories) and The Magstim Company Limited.
The strategic analysis for each of these companies has been covered in detail. The neurostimulation device market by company share helps to dive into the information about the key market players in this market and how much hold they have on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
NEUROSTIMULATION DEVICE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF SUPPLIERS
2.2.4. BARGAINING
POWER OF BUYERS
2.2.5. THREAT
OF RIVALRY
2.3. VALUE
CHAIN OUTLOOK
2.4. MARKET
TRENDS
2.5. MARKET
SHARE OUTLOOK
2.6. PESTLE
OUTLOOK
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHT
2.9. MARKET
DRIVERS
2.9.1. RISING
INCIDENCE OF NEURO DISEASES
2.9.2. INCREASING
GERIATRIC POPULATION
2.9.3. GROWING
DEMAND FOR MRI SCANS
2.9.4. FAVORABLE
REIMBURSEMENT POLICIES
2.10.
MARKET RESTRAINTS
2.10.1.
HIGH COST OF NEUROMODULATION
TREATMENT
2.10.2.
PRESENCE OF ALTERNATIVE
THERAPY
2.11.
MARKET OPPORTUNITIES
2.11.1.
HIGH MARKET POTENTIAL FOR SCS
DEVICES IN NEUROSTIMULATION
2.11.2.
TECHNOLOGICAL DEVELOPMENT
2.11.3.
GROWING INCIDENCE OF CHRONIC
DISCOMFORT
2.12.
MARKET CHALLENGES
2.12.1.
STRINGENT REGULATORY APPROVALS
2.12.2.
SIDE-EFFECTS ASSOCIATED WITH
NEUROSTIMULATION DEVICES
3. NEUROSTIMULATION
DEVICE MARKET OUTLOOK – BY SYSTEM
3.1. SPINAL
CORD STIMULATORS (SCS)
3.2. DEEP
BRAIN STIMULATORS (DBS)
3.3. SACRAL
NERVE STIMULATORS (SNS)
3.4. VAGUS
NERVE STIMULATORS (VNS)
3.5. GASTRIC
ELECTRIC STIMULATOR
3.6. OTHER
SYSTEMS
4. NEUROSTIMULATION
DEVICE MARKET OUTLOOK – BY APPLICATIONS
4.1. PAIN
MANAGEMENT
4.2. EPILEPSY
4.3. ESSENTIAL
TREMOR
4.4. URINARY
AND FECAL INCONTINENCE
4.5. DEPRESSION
4.6. DYSTONIA
4.7. GASTROPARESIS
4.8. PARKINSON’S
DISEASE
4.9. OTHER
APPLICATIONS
5. NEUROSTIMULATION
DEVICE MARKET – REGIONAL OUTLOOK
5.1. NORTH
AMERICA
5.1.1. MARKET
BY SYSTEM
5.1.2. MARKET
BY APPLICATION
5.1.3. COUNTRY
ANALYSIS
5.1.3.1. THE
UNITED STATES
5.1.3.2. CANADA
5.2. EUROPE
5.2.1. MARKET
BY SYSTEM
5.2.2. MARKET
BY APPLICATION
5.2.3. COUNTRY
ANALYSIS
5.2.3.1. THE
UNITED KINGDOM
5.2.3.2. FRANCE
5.2.3.3. GERMANY
5.2.3.4. SPAIN
5.2.3.5. ITALY
5.2.3.6. RUSSIA
5.2.3.7. REST
OF EUROPE
5.3. ASIA-PACIFIC
5.3.1. MARKET
BY SYSTEM
5.3.2. MARKET
BY APPLICATION
5.3.3. COUNTRY
ANALYSIS
5.3.3.1. INDIA
5.3.3.2. CHINA
5.3.3.3. JAPAN
5.3.3.4. AUSTRALIA
& NEW ZEALAND
5.3.3.5. SOUTH
KOREA
5.3.3.6. ASEAN
COUNTRIES
5.3.3.7. REST
OF ASIA-PACIFIC
5.4. LATIN
AMERICA
5.4.1. MARKET
BY SYSTEM
5.4.2. MARKET
BY APPLICATION
5.4.3. COUNTRY
ANALYSIS
5.4.3.1. BRAZIL
5.4.3.2. MEXICO
5.4.3.3. REST
OF LATIN AMERICA
5.5. MIDDLE
EAST AND AFRICA
5.5.1. MARKET
BY SYSTEM
5.5.2. MARKET
BY APPLICATION
5.5.3. COUNTRY
ANALYSIS
5.5.3.1. SAUDI
ARABIA
5.5.3.2. TURKEY
5.5.3.3. THE
UNITED ARAB EMIRATES
5.5.3.4. SOUTH
AFRICA
5.5.3.5. REST
OF MIDDLE EAST & AFRICA
6. COMPANY
PROFILES
6.1. NEURONETICS,
INC.
6.2. ST.
JUDE MEDICAL, INC. (ACQUIRED BY ABBOTT LABORATORIES)
6.3. HOCOMA
AG
6.4. NEVRO
CORP.
6.5. CYBERONICS
INC.
6.6. COGENTIX
MEDICAL, INC.
6.7. DEPUY
SYNTHES COMPANIES
6.8. DR.
LANGER MEDICAL GMBH
6.9. MEDTRONIC
PLC
6.10.
THE MAGSTIM COMPANY LIMITED
6.11.
ECTRON LIMITED
6.12.
BOSTON SCIENTIFIC CORPORATION
6.13.
EKSO BIONICS HOLDINGS INC.
6.14.
ALEVA NEUROTHERAPEUTICS SA
6.15.
HELIUS MEDICAL TECHNOLOGIES
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.1.1. OBJECTIVES
OF STUDY
7.1.2. SCOPE
OF STUDY
7.2. SOURCES
OF DATA
7.2.1. PRIMARY
DATA SOURCES
7.2.2. SECONDARY
DATA SOURCES
7.3. RESEARCH
METHODOLOGY
7.3.1. EVALUATION
OF PROPOSED MARKET
7.3.2. IDENTIFICATION
OF DATA SOURCES
7.3.3. ASSESSMENT
OF MARKET DETERMINANTS
7.3.4. DATA
COLLECTION
7.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 2 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLE 3 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 4 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027 (IN $ MILLION)
TABLE 5 NORTH
AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLE 6 NORTH
AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 7 CONDITIONS
TREATED BY NEUROSTIMULATION DEVICES IN THE UNITED STATES
TABLE 8 NORTH
AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 9 EUROPE
NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLE 10 EUROPE
NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 11 EUROPE
NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 12 ASIA-PACIFIC
NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLE 13 ASIA-PACIFIC
NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 14 ASIA-PACIFIC
NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 15 LATIN
AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLE 16 LATIN
AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 17 LATIN
AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 18 MIDDLE
EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLE 19 MIDDLE
EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($
MILLION)
TABLE 20 MIDDLE
EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 GLOBAL
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 2 VALUE
CHAIN OUTLOOK
FIGURE 3 PREVALENCE
OF MENTAL HEALTH DISORDERS 2012 AND 2020 (MILLION)
FIGURE 4 RISING
GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)
FIGURE 5 NEUROSTIMULATION
DEVICE COMPANY MARKET SHARE OUTLOOK 2018 (%)
FIGURE 6 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($
MILLION)
FIGURE 9 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($
MILLION)
FIGURE 11 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY EPILEPSY 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE 2019-2027 ($
MILLION)
FIGURE 16 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY DYSTONIA 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL
NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 21 THE
UNITED STATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 22 CANADA
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 23 THE
UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 24 FRANCE
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 25 GERMANY
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 26 SPAIN
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 27 ITALY
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 28 RUSSIA
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 29 REST
OF EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 30 INDIA
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 31 CHINA
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 32 JAPAN
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 33 AUSTRALIA
& NEW ZEALAND NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 34 SOUTH
KOREA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 35 ASEAN
COUNTRIES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 36 REST
OF ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 37 BRAZIL
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 38 MEXICO
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 39 REST
OF LATIN AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 40 SAUDI
ARABIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 41 TURKEY
NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 42 THE
UNITED ARAB EMIRATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 43 SOUTH
AFRICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 44 REST
OF MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($
MILLION)